Emerging paradigms of T-cell co-stimulation.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMID 15134781)

Published in Curr Opin Immunol on June 01, 2004

Authors

Richard A Kroczek1, Hans Werner Mages, Andreas Hutloff

Author Affiliations

1: Molecular Immunology, Robert Koch-Institute, Nordufer 20, 13353 Berlin, Germany.

Articles citing this

Use of tumour-responsive T cells as cancer treatment. Lancet (2009) 1.73

Human uterine epithelial cell secretions regulate dendritic cell differentiation and responses to TLR ligands. J Leukoc Biol (2010) 1.59

Antitumor immunity and cancer stem cells. Ann N Y Acad Sci (2009) 1.36

CD4 memory T cells survive and proliferate but fail to differentiate in the absence of CD40. J Exp Med (2006) 1.07

Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague. Infect Immun (2010) 1.05

Immunomodulatory therapy for melanoma: ipilimumab and beyond. Clin Dermatol (2013) 1.04

Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens. Curr Womens Health Rev (2008) 0.98

Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade. J Clin Invest (2015) 0.98

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. Haematologica (2010) 0.96

Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions. Cancer Biother Radiopharm (2014) 0.95

CD4 and CD8 T cells require different membrane gangliosides for activation. Proc Natl Acad Sci U S A (2012) 0.94

Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape? Front Immunol (2014) 0.93

Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells. Immunology (2006) 0.93

T-cell co-stimulatory pathways in autoimmunity. Arthritis Res Ther (2008) 0.91

Genetic defects in common variable immunodeficiency. Int J Immunogenet (2007) 0.90

Novel therapeutic and prevention approaches for schistosomiasis: review. J Adv Res (2012) 0.89

SAP-mediated inhibition of diacylglycerol kinase α regulates TCR-induced diacylglycerol signaling. J Immunol (2011) 0.88

Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol. J Leukoc Biol (2008) 0.88

Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells. Exp Mol Pathol (2011) 0.88

Immunomodulatory monoclonal antibodies combined with peptide vaccination provide potent immunotherapy in an aggressive murine neuroblastoma model. Clin Cancer Res (2013) 0.85

Effect of oestradiol and pathogen-associated molecular patterns on class II-mediated antigen presentation and immunomodulatory molecule expression in the mouse female reproductive tract. Immunology (2012) 0.82

Nickel induces secretion of IFN-gamma by splenic natural killer cells. Exp Mol Med (2009) 0.81

ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosis. J Int AIDS Soc (2012) 0.81

Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells. J Immunother Cancer (2013) 0.81

Genotype and phenotype predictors of relapse of graves' disease after antithyroid drug withdrawal. Eur Thyroid J (2012) 0.80

The inducible costimulator augments Tc17 cell responses to self and tumor tissue. J Immunol (2015) 0.80

In vitro differentiation of adult bone marrow progenitors into antigen-specific CD4 helper T cells using engineered stromal cells expressing a notch ligand and a major histocompatibility complex class II protein. Stem Cells Dev (2009) 0.80

Down-regulation of CTLA-4 by HIV-1 Nef protein. PLoS One (2013) 0.79

HVEM gene polymorphisms are associated with sporadic breast cancer in Chinese women. PLoS One (2013) 0.78

Molecular insights into γδ T cell costimulation by an anti-JAML antibody. Structure (2011) 0.78

Endothelial cells potentiate interferon-γ production in a novel tripartite culture model of human cerebral malaria. PLoS One (2013) 0.78

Dynamic regulation of Gata1 expression during the maturation of conventional dendritic cells. Exp Hematol (2010) 0.77

Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation. J Gen Virol (2015) 0.77

Regulatory mechanisms of injury and repair after hepatic ischemia/reperfusion. Scientifica (Cairo) (2012) 0.77

Effector function of CTLs is increased by irradiated colorectal tumor cells that modulate OX-40L and 4-1BBL and is reversed following dual blockade. BMC Res Notes (2016) 0.75

CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo. J Clin Invest (2016) 0.75

Articles by these authors

Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol (2003) 3.16

Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature (2007) 3.08

Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. Immunity (2009) 2.17

T-follicular helper cells survive as long-term memory cells. Eur J Immunol (2012) 2.05

Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med (2003) 1.89

Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS. Immunity (2009) 1.70

ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol (2008) 1.62

Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE. Eur J Immunol (2010) 1.58

ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci U S A (2002) 1.28

Cutting edge: Plasmacytoid dendritic cells induce IL-10 production in T cells via the Delta-like-4/Notch axis. J Immunol (2009) 1.22

ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells. Eur J Immunol (2002) 1.19

Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis. Ann Rheum Dis (2010) 1.12

Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J Allergy Clin Immunol (2012) 1.06

Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity. J Immunol (2004) 1.03

ICOS+ Th cells produce distinct cytokines in different mucosal immune responses. Eur J Immunol (2003) 1.03

Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells. Immunology (2006) 0.93

Inducible costimulator-positive T cells are required for allergen-induced local B-cell infiltration and antigen-specific IgE production in lung tissue. J Allergy Clin Immunol (2004) 0.87

Comprehensive analysis of CD4+ T cells in the decision between tolerance and immunity in vivo reveals a pivotal role for ICOS. J Immunol (2012) 0.84

Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease. Exp Lung Res (2009) 0.80

Impact of inducible co-stimulatory molecule (ICOS) on T-cell responses and protection against Mycobacterium tuberculosis infection. Eur J Immunol (2011) 0.78

Cytomegalovirus expresses the chemokine homologue vXCL1 capable of attracting XCR1+ CD4- dendritic cells. J Virol (2013) 0.78